TROP2 ADC

CHENGDU, China — August 17, 2026 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) reported its unaudited interim results for the...

CHENGDU, China, July 14, 2026 Kelun-Biotech has announced a major clinical milestone after its Phase III OptiTROP-Lung06 trial evaluating...

Rahway, N.J., USA – May 18, 2026 Merck announced that its pivotal Phase 3 TroFuse-005 clinical trial evaluating sacituzumab...